I sarcomi dei tessuti molli

Size: px
Start display at page:

Download "I sarcomi dei tessuti molli"

Transcription

1 Novità e sequenze terapeutiche nelle neoplasie ginecologiche, melanoma e tumori rari: I sarcomi dei tessuti molli Giacomo G. Baldi Oncologia Medica Sandro Pitigliani Nuovo Ospedale S.Stefano Azienda USL Toscana centro Prato

2 Adipocytic tumours Well deifferentiated / dedifferentiated liposarcoma Myxoid / round cell liposarcoma Pleomorphic liposarcoma Fibroblastic / myofibroblastic tumours Fibromatosis (desmoid) DFSP Solitary fibrous tumour / haemangiopericytoma IMT Low grade myofibroblastic sarcoma Infantile fibrosarcoma Adult fibrosarcoma Mixofibrosarcoma SEF LGFMS Smooth muscle tumours Leiomyosarcoma Skeletal muscle tumours Embryonal rhabdomyosarcoma Alveolar rhabdomyosarcoma Pleomorphic rhabdomyosarcoma Vascular tumours Epithelioid haemangioendothelioma Angiosarcoma of soft tissue GIST Nerve sheath tumors MPNST Malignant GCT Chondro-osseous tumours Mesenchymal chondrosarcoma Extraskeletal osteosarcoma Tumours of uncertain differentiation Synovial sarcoma Epithelioid sarcoma Alveolar soft part sarcoma Clear cell sarcoma of soft tissue Extraskeletal myxoid chondrosarcoma Extraskeletal Ewing sarcoma Desmoplastic small round cell tumour Extra-renal rhabdoid tumour Malignant mesenchymoma Malignant PEComa Intimal sarcoma Fletcher CDM et al, WHO Classification 2013

3 Soft tissue sarcoma Courtesy A.P. Dei Tos

4 Soft tissue sarcoma # 1463 pts Full 56% Partial 35% Zero 8% Ray-Coquard I et al, Ann Oncol 2012

5 Soft tissue sarcoma: localised disease Soft tissue sarcoma-high risk-primary and localised disease completely resected/resectable standard: surgery +/- RT (neo) adjuvant systemic treatment to increase the chance of cure

6 Soft tissue sarcoma: localised disease 5-10% absolute improvement in OS Pervaiz et al, Cancer 2008

7 Soft tissue sarcoma: localised disease # 351 pts Median FUP 8 yrs Adm 75 mg/sqm + Ifo 5 g/sqm G2 and G3 (46%) Any histology (90 pts other histo) Woll et al, Lancet Oncol 2012

8 Soft tissue sarcoma: localised disease epiadm 120 mg/sqm + IFX 9 g/sqm q 21 days Frustaci et al, J Clin Oncol 2001 Gronchi et al, J Clin Oncol 2012

9 Soft tissue sarcoma: localised disease Gronchi et al, Lancet Oncol 2017

10 Soft tissue sarcoma: localised disease Median FUP 12.6 months Gronchi et al, Lancet Oncol 2017

11 Soft tissue sarcoma: localised disease Weaknesses One-sided significance test No control arm Short median follow-up (12.6 months) Actions taken Amendment to two-sided significance test Final analysis awaited Strengths Significance both in DFS and OS Size of the effect Persistent difference in DFS in 2 indipendent sets of observations Effect on DM free survival Gronchi et al, Lancet Oncol 2017

12 Soft tissue sarcoma: localised disease Longer FU is needed but the shape of the curve of the standard arm is superimposable to the previous study

13 Soft tissue sarcoma: localised disease (Neo) adjuvant chemotherapy not standard High risk Waiting for the final analysis of the STS-ISG study

14 Soft tissue sarcoma: advanced disease Tap et al, Lancet 2016

15 Soft tissue sarcoma: advanced disease Tap et al, Lancet 2016

16 Soft tissue sarcoma: advanced disease Tap et al, Lancet 2016

17 Soft tissue sarcoma: advanced disease Weaknesses Unknown mechanisms of actions Discrepancy between PFS and OS improvement Limited number of patients Actions taken Phase 1b study ongoing in potentially resectable patients Phase 1 study ongoing olara plus doxorubicin and ifosfamide vs doxorubicin and ifosfamide Phase 3 study completed, results awaited Strengths First study showing a improvement in OS Magnitude of improvement Tap et al, Lancet 2016

18 Soft tissue sarcoma: advanced disease Novel standard? Patient selection (need for tumor shrinkage, histology) Doxorubicin: 8 cycles? (75 mg/smq = 600 mg/smq) Cardioxane administration (off label) Tap et al, Lancet 2016

19 Soft tissue sarcoma: advanced disease further line Schöffski et al, Lancet 2016

20 Soft tissue sarcoma: advanced disease further line Schöffski et al, Lancet 2016

21 Soft tissue sarcoma: advanced disease further line Schöffski et al, Lancet 2016

22 Soft tissue sarcoma: advanced disease further line Schöffski et al, Lancet 2016 X Demetri et al, J Clin Oncol 2017

23 Soft tissue sarcoma: advanced disease further line Demetri et al, J Clin Oncol 2017

24 Soft tissue sarcoma: advanced disease further line Progressive WD/DD retroperitoneal LPS 4 th line Eribulin X 3

25 Soft tissue sarcoma: what future? Frezza et al, BMC Med 2017

26 Soft tissue sarcoma: what future? Phase I-II trial of sunitinib plus nivolumab after standard treatment in advanced soft tissue and bone sarcomas Main inclusion criteria Histologic diagnosis of soft tissue sarcoma (undifferentiated pleomorphic sarcoma, synovial sarcoma, alveolar soft part sarcoma, clear cell sarcoma, angiosarcoma, epithelioid hemangiosarcoma, solitary fibrous tumor and epithelioid sarcomas) or bone sarcoma (osteosarcoma/high grade bone sarcoma, Ewing sarcoma or dedifferentiated chondrosarcoma) Pathology specimens available for centralized review ECOG PS <=2 Patients have previously received at least anthracyclines Main exclusion criteria Three or more previous lines of chemotherapy for the advanced disease

27 Soft tissue sarcoma: conclusions Sarcomas are heterogeneous Accurate diagnosis is a challenge Referral to expert rare cancer pathologist Multidisciplinar approach in referral institutions

28 Networks are the best tool for proper referral

29

La chemioterapia neoadiuvante nei sarcomi: novità e attuali indicazioni Lorenzo D Ambrosio, MD PhD Divisione di Oncologia Medica Istituto di Candiolo

La chemioterapia neoadiuvante nei sarcomi: novità e attuali indicazioni Lorenzo D Ambrosio, MD PhD Divisione di Oncologia Medica Istituto di Candiolo La chemioterapia neoadiuvante nei sarcomi: novità e attuali indicazioni Lorenzo D Ambrosio, MD PhD Divisione di Oncologia Medica Istituto di Candiolo Fondazione del Piemonte per l Oncologia. IRCCS 12 CONGRESSO

More information

Managing adult soft tissue sarcomas and gastrointestinal stromal tumours

Managing adult soft tissue sarcomas and gastrointestinal stromal tumours Managing adult soft tissue sarcomas and gastrointestinal stromal tumours Sarcomas and gastrointestinal stromal tumours include a wide variety of biologically diverse cancers, many of them very rare. Paolo

More information

Update on Sarcomas of the Head and Neck. Kevin Harrington

Update on Sarcomas of the Head and Neck. Kevin Harrington Update on Sarcomas of the Head and Neck Kevin Harrington Overview Classification and incidence of sarcomas Clinical presentation Challenges to treatment Management approaches Prognostic factors Radiation-induced

More information

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology

Contents Part I Introduction 1 General Description 2 Natural History: Importance of Size, Site, Histopathology Contents Part I Introduction 1 General Description... 3 1.1 Introduction... 3 1.2 Incidence and Prevalence... 5 1.3 Predisposing and Genetic Factors... 8 References... 16 2 Natural History: Importance

More information

The hunting of the sarcoma

The hunting of the sarcoma The hunting of the sarcoma Update of Recent Advances in Soft Tissue Sarcoma Treatment Lin Mei, MD Hematology-Oncology Fellow Educational goal Anecdote of sarcoma (10 quiz) Review of pathology Neoadjuvant

More information

Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities

Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities Predictive biomarker profiling of > 1,900 sarcomas: Identification of potential novel treatment modalities Sujana Movva 1, Wenhsiang Wen 2, Wangjuh Chen 2, Sherri Z. Millis 2, Margaret von Mehren 1, Zoran

More information

Épidémiologie des sarcomes en Belgique

Épidémiologie des sarcomes en Belgique 1 Épidémiologie des sarcomes en Belgique Dr. Liesbet Van Eycken 12 es journées annuelles du GSF-GETO Oud Sint-Jan Bruges, 22-24 juin 2016 Overview Introduction Descriptive epidemiology Incidence Age specific

More information

Molecular pathology in soft tissue tumors. Sylvia Höller Pathologie

Molecular pathology in soft tissue tumors. Sylvia Höller Pathologie Molecular pathology in soft tissue tumors Sylvia Höller Pathologie When do we perform molecular testing? Morphology and IHC are not clearly fitting with an entity some translocations are entity specific

More information

The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository

The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository The Completeness of Soft Tissue Sarcoma Data in the National Cancer Data Repository Tumours diagnosed between 2006 and 2008 West Midlands Cancer Intelligence Unit Completeness of cancer data 2008 Soft

More information

Best of ASCO 2014 Sarcoma

Best of ASCO 2014 Sarcoma Best of ASCO 2014 Sarcoma Robin L Jones Seattle Cancer Care Alliance University of Washington Fred Hutchinson Cancer Research Center Presentation Outline Overview progress made in sarcoma Highlight 2 trials

More information

Recommendations for Reporting Soft Tissue Sarcomas

Recommendations for Reporting Soft Tissue Sarcomas A J C P / REPORTING SOFT TISSUE SARCOMAS Recommendations for Reporting Soft Tissue Sarcomas Association of Directors of Anatomic and Surgical Pathology Key Words: Sarcoma; Soft tissue tumors Abstract The

More information

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON

Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Pathology of Sarcoma ELEANOR CHEN, MD, PHD, ASSISTANT PROFESSOR DEPARTMENT OF PATHOLOGY UNIVERSITY OF WASHINGTON Presentation outline Background and epidemiology of sarcomas Sarcoma classification Sarcoma

More information

Klinisch belang van chromosomale translocatie detectie in sarcomen

Klinisch belang van chromosomale translocatie detectie in sarcomen Translocations in sarcomas Klinisch belang van chromosomale translocatie detectie in sarcomen Judith V.M.G. Bovée, M.D., Ph.D. Department of Pathology Leiden University Medical Center RNA binding DNA binding

More information

WHO Classification of Soft Tissue Tumours

WHO Classification of Soft Tissue Tumours WHO Classification of Soft Tissue Tumours This new WHO classification of soft tissue tumours, in line with other volumes in this new series, incorporates detailed clinical, histological and genetic data.

More information

Rare Cancers. Andrew J. Wagner, MD, PhD Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute Sarcoma Patient Symposium October 15, 2017

Rare Cancers. Andrew J. Wagner, MD, PhD Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute Sarcoma Patient Symposium October 15, 2017 Rare Cancers Andrew J. Wagner, MD, PhD Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute Sarcoma Patient Symposium October 15, 2017 Why should we care about Rare Cancers? Raise your hand

More information

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques

More information

Soft Tissue Sarcomas: Questions and Answers

Soft Tissue Sarcomas: Questions and Answers Soft Tissue Sarcomas: Questions and Answers 1. What is soft tissue? The term soft tissue refers to tissues that connect, support, or surround other structures and organs of the body. Soft tissue includes

More information

Diagnosis and management of retroperitoneal sarcoma

Diagnosis and management of retroperitoneal sarcoma SON Update 2017 Diagnosis and management of retroperitoneal sarcoma Andrea J MacNeill, MD MSc FRCSC Surgical Oncologist, BC Cancer Agency Vancouver 2 Histologic Subtypes of STS 3 RP Subtypes (n=684) Extremity

More information

Histotype or molecular driven treatment of sarcomas?

Histotype or molecular driven treatment of sarcomas? Histotype or molecular driven treatment of sarcomas? Prof.ssa Maria A Pantaleo Dipartimento Medicina Specialistica, Diagnostica e Sperimentale Università di Bologna GistStudyGroup Sarcomastudygroup Bologna

More information

Scandinavian Sarcoma Group and Oncologic Center, Lund, Sweden. Centralized Registration of Sarcoma Patients in Scandinavia SSG VII:4

Scandinavian Sarcoma Group and Oncologic Center, Lund, Sweden. Centralized Registration of Sarcoma Patients in Scandinavia SSG VII:4 Scandinavian Sarcoma Group and Oncologic Center, Lund, Sweden Centralized Registration of Sarcoma Patients in Scandinavia SSG VII:4 Modified April, 2009 Scandinavian Sarcoma Group & Oncologic Center, Lund,

More information

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction

Disclosures. An update on ancillary techniques in the diagnosis of soft tissue tumors. Ancillary techniques. Introduction Disclosures An update on ancillary techniques in the diagnosis of soft tissue tumors. I have nothing to disclose. Andrew Horvai, MD, PhD Clinical Professor, Pathology Introduction Ancillary techniques

More information

ORIGINAL ARTICLE Histopathological diagnoses in soft tissue tumours: an experience from a tertiary centre in Malaysia

ORIGINAL ARTICLE Histopathological diagnoses in soft tissue tumours: an experience from a tertiary centre in Malaysia Malaysian J Pathol 2017; 39(3) : 209 216 ORIGINAL ARTICLE Histopathological diagnoses in soft tissue tumours: an experience from a tertiary centre in Malaysia Nur Dini JALALUDIN MB Bch BAO, Noraini MOHD

More information

Clinical Study A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas

Clinical Study A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas Sarcoma Volume 2006, Article ID 5947, Pages 4 DOI 0.55/SRCM/2006/5947 Clinical Study A Retrospective Analysis of Vinorelbine Chemotherapy for Patients With Previously Treated Soft-Tissue Sarcomas Sibyl

More information

Case Presentation. Gordon Callender M.D. Surgical Resident

Case Presentation. Gordon Callender M.D. Surgical Resident Case Presentation Gordon Callender M.D. Surgical Resident Retroperitoneal Sarcomas Sarcomas Heterogeneous group of rare tumors that arise predominantly from the embryonic mesoderm. Expected incidence for

More information

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk

Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk 843 Prognostic Significance of Grading and Staging Systems using MIB-1 Score in Adult Patients with Soft Tissue Sarcoma of the Extremities and Trunk Tadashi Hasegawa, M.D. 1 Seiichiro Yamamoto, Ph.D. 2

More information

The evidence for and against neoadjuvant chemotherapy in localized STS

The evidence for and against neoadjuvant chemotherapy in localized STS The evidence for and against neoadjuvant chemotherapy in localized STS Axel Le Cesne Gustave Roussy, Villejuif French Sarcoma Group EORTC, CTOS Académie de Médecine Drugs Practice, 2 nd of December 2016

More information

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD

Immunohistochemistry in Bone and Soft Tissue Tumors. Sahar Rassi Zankoul, MD Immunohistochemistry in Bone and Soft Tissue Tumors Sahar Rassi Zankoul, MD Introduction Bone tumors represent a wide variety of tumors of various origins and malignant potentials. These different tumor

More information

International Collaborations on Sarcomas. Alessandro Gronchi

International Collaborations on Sarcomas. Alessandro Gronchi International Collaborations on Sarcomas Alessandro Gronchi alessandro.gronchi@istitutotumori.mi.it EORTC STBSG World Sarcoma Network Investigators initiated Trials (national groups, centers, etc.) 33

More information

Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon

Introduction to Musculoskeletal Tumors. James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon Introduction to Musculoskeletal Tumors James C. Wittig, MD Orthopedic Oncologist Sarcoma Surgeon www.tumorsurgery.org Definitions Primary Bone / Soft tissue tumors Mesenchymally derived tumors (Mesodermal)

More information

PROBLEMS OF PROGNOSTICATION IN SOFT TISSUE TUMOURS. Christopher D.M. Fletcher Brigham and Women s Hospital and Harvard Medical School Boston, MA

PROBLEMS OF PROGNOSTICATION IN SOFT TISSUE TUMOURS. Christopher D.M. Fletcher Brigham and Women s Hospital and Harvard Medical School Boston, MA PROBLEMS OF PROGNOSTICATION IN SOFT TISSUE TUMOURS Christopher D.M. Fletcher Brigham and Women s Hospital and Harvard Medical School Boston, MA Dr. Fletcher has no conflict of interest or disclosures to

More information

Multidisciplinary management of retroperitoneal sarcomas

Multidisciplinary management of retroperitoneal sarcomas Multidisciplinary management of retroperitoneal sarcomas Eric K. Nakakura, MD UCSF Department of Surgery UCSF Comprehensive Cancer Center San Francisco, CA 7 th Annual Clinical Cancer Update North Lake

More information

Perspectives in 2 nd line treatment of advanced Soft tissue Sarcoma treatment approaches. Dr.Dana Stănculeanu Bucharest Institute of Oncology

Perspectives in 2 nd line treatment of advanced Soft tissue Sarcoma treatment approaches. Dr.Dana Stănculeanu Bucharest Institute of Oncology Perspectives in 2 nd line treatment of advanced Soft tissue Sarcoma treatment approaches Dr.Dana Stănculeanu Bucharest Institute of Oncology Epidemiology of soft tissue sarcoma STS accounts for

More information

Adult-type soft tissue sarcomas are a variegate group of

Adult-type soft tissue sarcomas are a variegate group of Adjuvant Chemotherapy for Soft Tissue Sarcoma Paolo G. Casali, MD OVERVIEW Adjuvant chemotherapy is not standard treatment in soft tissue sarcoma (STS). However, when the risk of relapse is high, it is

More information

Conceptual Evolution of Soft Tissue Tumors Classification

Conceptual Evolution of Soft Tissue Tumors Classification Conceptual Evolution of Soft Tissue Tumors Classification Angelo P. Dei Tos M.D. Departments of Pathology & Oncology Treviso, Italy How WHO classification was reshaped Pathologists and Cytogeneticists

More information

Financial disclosures

Financial disclosures An update on immunohistochemical markers in mesenchymal neoplasms By Konstantinos Linos MD, FCAP, FASDP Assistant Professor of Pathology Geisel School of Medicine at Dartmouth Dartmouth-Hitchcock Medical

More information

Ian Judson and Winette T. van der Graaf

Ian Judson and Winette T. van der Graaf SARCOMA Olaratumab really a breakthrough for soft-tissue sarcomas? Ian Judson and Winette T. van der Graaf In a recent study, the addition of olaratumab to doxorubicin chemotherapy for patients with soft-tissue

More information

Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017)

Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version (downloaded 3/23/2017) APPENDIX I. SEER Search criteria and exclusion criteria. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat version 8.3.4 (downloaded 3/23/2017) SEER*Stat Database:

More information

5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani

5/10. Pathology Soft tissue tumors. Farah Bhani. Mohammed Alorjani 5/10 Pathology Soft tissue tumors Mohammed Alorjani Farah Bhani Slides are included in this sheet. Objectives: Soft tissue tumors 1. Describe soft tissue tumors. 2. Understand the classification of soft

More information

Diagnostic Approach to Soft Tissue Tumors

Diagnostic Approach to Soft Tissue Tumors SECTION 2 Diagnostic Approach to Soft Tissue Tumors Overview Biopsy and Resection of Soft Tissue Tumors 20 Clinical Approach Age- and Location-Based Approach to Diagnosis 24 Histologic Approach Pattern-Based

More information

Dystrophin Is a Tumor Suppressor in Human Cancers with Myogenic Programs

Dystrophin Is a Tumor Suppressor in Human Cancers with Myogenic Programs SUPPLEMENTARY INFORMATION Dystrophin Is a Tumor Suppressor in Human Cancers with Myogenic Programs Yuexiang Wang 1, Adrian Marino-Enriquez 1, Richard R. Bennett 2, Meijun Zhu 1, Yiping Shen 3,4, Grant

More information

Khin Thway, Jayson Wang, Taka Mubako, and Cyril Fisher. 1. Introduction

Khin Thway, Jayson Wang, Taka Mubako, and Cyril Fisher. 1. Introduction Sarcoma, Article ID 686902, 7 pages http://dx.doi.org/10.1155/2014/686902 Research Article Histopathological Diagnostic Discrepancies in Soft Tissue Tumours Referred to a Specialist Centre: Reassessment

More information

Trabectedin in ASTS. Le Cesne A, et al. J Clin Oncol. 2018;36(suppl): Abstract

Trabectedin in ASTS. Le Cesne A, et al. J Clin Oncol. 2018;36(suppl): Abstract Results of a Prospective Randomized Phase III T-SAR Trial Comparing Trabectedin vs Best Supportive Care (BSC) in Patients With Pretreated Advanced Soft Tissue Sarcoma (ASTS) Abstract 11508 Le Cesne A,

More information

XXII Congresso Nazionale AIRO

XXII Congresso Nazionale AIRO XXII Congresso Nazionale AIRO Roma, 17-20 Novembre 2012. I Sarcomi delle Parti Molli dell adulto: Terapia Adiuvante vs Terapia Neoadiuvante Antonino De Paoli UO Oncologia Radioterapica Centro di Riferimento

More information

Day 1: ESMO Sarcoma & GIST Faculty closed meeting

Day 1: ESMO Sarcoma & GIST Faculty closed meeting Day 1: ESMO Sarcoma & GIST Faculty closed meeting Sunday, 4 February 2018 12:30 14:00 Lunch 14:00-16:00 Discussion: Should we routinely use NGS? 120 Panel discussion 16:00 16:30 Coffee Break 16:30-18:00

More information

Therapeutic Algorithms in systemic sarcoma therapy

Therapeutic Algorithms in systemic sarcoma therapy Therapeutic Algorithms in systemic sarcoma therapy Ian Judson Sarcoma Unit Royal Marsden Hospital What evidence do we have? What sorts of evidence are there? Experience personal, peers ( Bayesian ) Educational

More information

Pan Arab Journal of Oncology

Pan Arab Journal of Oncology Pan Arab Journal of Oncology Original Article Retrospective Analysis of Clinicopathologic and Management Aspects of Soft Tissue Sarcoma Tarek Hussein Kamel, Azza Mohamed Adel, Reham Mohamed Faheim, Rana

More information

Summary... 2 SARCOMA Neoadjuvant chemotherapy in patients with localised high-risk STS... 3

Summary... 2 SARCOMA Neoadjuvant chemotherapy in patients with localised high-risk STS... 3 ESMO 2016 Congress 7-11 October, 2016 Copenhagen, Denmark Table of Contents Summary... 2 SARCOMA... 3 Neoadjuvant chemotherapy in patients with localised high-risk STS... 3 No additional benefit with evofosfamide

More information

Trends in presentation of bone and soft tissue sarcomas over 25 years little evidence of earlier diagnosis

Trends in presentation of bone and soft tissue sarcomas over 25 years little evidence of earlier diagnosis Trends in presentation of bone and soft tissue sarcomas over 25 years little evidence of earlier diagnosis Royal Orthopaedic Hospital, Birmingham Rob Grimer, Lee Jeys, Gemma Smith, Graham Johnson Are we

More information

During the dose-finding phase, patients will be non-randomly assigned to treatment with pazopanib. (Regimen A) (Regimen C)

During the dose-finding phase, patients will be non-randomly assigned to treatment with pazopanib. (Regimen A) (Regimen C) EXPERIMENTAL DESIGN SCHEMAS DOSE FINDING PHASE During the dose-finding phase, patients will be non-randomly assigned to treatment with pazopanib. Chemotherapy Cohort Non-Chemotherapy Cohort (Regimen A)

More information

Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors

Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors Original Article DOI: 10.21276/APALM.1637 Diagnostic Value of Immunohistochemistry in Soft Tissue Tumors Sridevi. V*., Susruthan Muralitharan., and Thanka. J Dept of Pathology, SriMuthukumaran Medical

More information

INDEX. in this web service Cambridge University Press

INDEX. in this web service Cambridge University Press actin 14 adamantinoma 202, 290 292, 297 adenocarcinoma 136 adipocytes in hibernoma 149, 150 in lipoblastoma 148 in lipoma 141, 142, 145 in liposarcoma 152 in myelolipoma 151 adrenal gland tumors see myelolipoma

More information

Com cal fer la primera maniobre terapèutica en els sarcomes d extremitats. Tractament sistèmic.

Com cal fer la primera maniobre terapèutica en els sarcomes d extremitats. Tractament sistèmic. Com cal fer la primera maniobre terapèutica en els sarcomes d extremitats. Tractament sistèmic. Dr. Javier Martín Broto Oncología Médica. HU Son Espases. Palma www.cotmes.com DIAGNOSTIC PROCEDURE: CRUCIAL

More information

Research Article Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network

Research Article Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue Sarcoma in a Community-Based Oncology Network Hindawi Publishing Corporation Sarcoma Volume 2014, Article ID 145764, 7 pages http://dx.doi.org/10.1155/2014/145764 Research Article Epidemiology, Treatment Patterns, and Outcomes of Metastatic Soft Tissue

More information

Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival

Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival 1366 Original Research Patterns of Chemotherapy Administration in High-Risk Soft Tissue Sarcoma and Impact on Overall Survival Sujana Movva, MD a ; Margaret von Mehren, MD a ; Eric A. Ross, PhD b ; and

More information

Musculoskeletal Sarcomas

Musculoskeletal Sarcomas Musculoskeletal Sarcomas Robert C. Orth, M.D., Ph.D. Edward B. Singleton Department of Pediatric Radiology Texas Children s Hospital Page 0 xxx00.#####.ppt 9/23/2012 9:01:18 AM No disclosures Page 1 xxx00.#####.ppt

More information

Soluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors

Soluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors Soluble CD155 As A Biomarker For Malignant Bone And Soft Tissue Tumors Mikinobu Goto, MD, Akihiko Matsumine, MD,PhD, Tomoki Nakamura, MD PhD, Takao Matsubara, MD PhD, Kunihiro Asanuma, MD,PhD, Toru Oi,

More information

Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS.

Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Thank you for agreeing to give us a statement on your organisation s view of the technology and the way it should be used in the NHS. Healthcare professionals can provide a unique perspective on the technology

More information

New and Emerging Therapies for Soft Tissue Sarcomas and GIST: Recent Clinical Data and Expert Recommendations

New and Emerging Therapies for Soft Tissue Sarcomas and GIST: Recent Clinical Data and Expert Recommendations New and Emerging Therapies for Soft Tissue Sarcomas and GIST: Recent Clinical Data and Expert Recommendations George D. Demetri, M.D. Director, Center for Sarcoma and Bone Oncology Dana-Farber Cancer Institute

More information

Research Article High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma

Research Article High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma Hindawi Sarcoma Volume 2017, Article ID 3739159, 5 pages https://doi.org/10.1155/2017/3739159 Research Article High-Dose Ifosfamide Chemotherapy in a Series of Patients Affected by Myxoid Liposarcoma Vittoria

More information

* I have no disclosures or any

* I have no disclosures or any Howard Rosenthal, M.D. Associate Professor of Orthopedic Surgery University of Kansas Sarcoma Center I have no disclosures or any conflicts related to the content of this presentation. Objectives 1. Describe

More information

Chapter 2 Natural History: Importance of Size, Site, and Histopathology

Chapter 2 Natural History: Importance of Size, Site, and Histopathology Chapter 2 Natural History: Importance of Size, Site, and Histopathology Natural History The natural history of soft tissue sarcoma is highly in fl uenced by the site of the primary lesion, tumor histopathology,

More information

Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology

Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology Rhabdomyomas and Rhabdomyosarcomas (RMS) David M. Parham, MD Chief of Anatomic Pathology Tumors of skeletal muscle: Rhabdomyomas and rhabdomyosarcomas Embryonal muscle 2 3 4 5 6 7 8 Rhabdomyoma Benign

More information

Particolarità molecolari delle neoplasie sarcomatose: Quale lezione biologica possiamo trarre per tutte le altre neoplasie?

Particolarità molecolari delle neoplasie sarcomatose: Quale lezione biologica possiamo trarre per tutte le altre neoplasie? Particolarità molecolari delle neoplasie sarcomatose: Quale lezione biologica possiamo trarre per tutte le altre neoplasie? Bruno Vincenzi, MD PhD Università Campus Bio-Medico di Roma Defining sarcoma

More information

Q&A. Fabulous Prizes. Collecting Cancer Data: Bone and Soft Tissue 1/10/113. NAACCR Webinar Series

Q&A. Fabulous Prizes. Collecting Cancer Data: Bone and Soft Tissue 1/10/113. NAACCR Webinar Series Collecting Cancer Data Bone & Soft Tissue NAACCR 2012 2013 Webinar Series Q&A Please submit all questions concerning webinar content through the Q&A panel. Reminder: If you have participants watching this

More information

Methoden / Methods inc. ICCC-3 105

Methoden / Methods inc. ICCC-3 105 Methoden / Methods inc. ICCC-3 105 Internationale Klassifikation der Krebserkrankungen bei Kindern (ICCC-3) Zuordnung von ICD-O-3-Codes für Morphologie und Topographie zu diagnostischen Kategorien International

More information

Sarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center

Sarcomas. Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Sarcomas Living Beyond Cancer A-Z UT Health San Antonio MD Anderson Cancer Center Aaron Sugalski, DO Associate Professor of Pediatric Hematology/Oncology Medical Director, UHS Pediatric Blood and Cancer

More information

HOW MAY THE CLASSIFICATION OF SOFT TISSUE TUMORS EVOLVE?

HOW MAY THE CLASSIFICATION OF SOFT TISSUE TUMORS EVOLVE? Spanish Society of Pathology Zaragoza, May 2011 ARTHUR PURDY STOUT SYMPOSIUM HOW MAY THE CLASSIFICATION OF SOFT TISSUE TUMORS EVOLVE? Christopher D.M. Fletcher, M.D., FRCPath Brigham and Women s Hospital

More information

Rome, November th 2018

Rome, November th 2018 Rome, November 15-18 th 2018 Can wait and see be the standard of care for initial approach to primary sporadic desmoid tumors? Preliminary data from an Italian Sarcoma Group prospective study Colombo C,

More information

pan-canadian Oncology Drug Review Final Clinical Guidance Report Pazopanib (Votrient) for Soft Tissue Sarcoma November 29, 2012

pan-canadian Oncology Drug Review Final Clinical Guidance Report Pazopanib (Votrient) for Soft Tissue Sarcoma November 29, 2012 pan-canadian Oncology Drug Review Final Clinical Guidance Report Pazopanib (Votrient) for Soft Tissue Sarcoma November 29, 2012 DISCLAIMER Not a Substitute for Professional Advice This report is primarily

More information

Dr. Myo Myint Maw Senior Consultant Physician Medical Oncology Unit Yangon General Hospital

Dr. Myo Myint Maw Senior Consultant Physician Medical Oncology Unit Yangon General Hospital Dr. Myo Myint Maw Senior Consultant Physician Medical Oncology Unit Yangon General Hospital *Sarcoma constitutes 2% of cancer patients attended at medical oncology unit of Yangon General Hospital.(2014-2015)

More information

Grading of Bone Tumors

Grading of Bone Tumors Grading of Bone Tumors Joon Hyuk Choi, M.D. Department of Pathology College of Medicine, Yeungnam University Introduction to grading system of bone tumor used at Mayo Clinic WHO Histologic Classification

More information

Journal of Solid Tumors, April 2012, Vol. 2, No. 2

Journal of Solid Tumors, April 2012, Vol. 2, No. 2 ORIGINAL ARTICLE Utility of fluorescence in situ hybridization in subclassifying unclassified high-grade sarcomas: A study of 40 cases using break-apart probes of EWSR1, FOXO1A, SS18 and DDIT3 genes Alfredo

More information

Guidelines for the management of soft tissue sarcomas. The British Sarcoma Group Authors:

Guidelines for the management of soft tissue sarcomas. The British Sarcoma Group Authors: Guidelines for the management of soft tissue sarcomas. The British Sarcoma Group Authors: Mr Robert Grimer Consultant Orthopaedic Surgeon, Royal Orthopaedic Hospital, Birmingham Prof Ian Judson Consultant

More information

RARE TUMORS OF INFANCY. RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital

RARE TUMORS OF INFANCY. RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital RARE TUMORS OF INFANCY RAJKUMAR VENKATRAMANI, MD, MS Director, Rare Tumors Program, Texas Children s Hospital OBJECTIVES Review the epidemiology and clinical presentation of soft tissue sarcomas in infancy.

More information

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn

Update on Cutaneous Mesenchymal Tumors. Thomas Brenn Update on Cutaneous Mesenchymal Tumors Thomas Brenn Cutaneous Mesenchymal Tumours Wide morphological and biological spectrum Myofibroblastic, smooth muscle, neural, vascular, apidocytic, undifferentiated;

More information

Protocol for the Examination of Specimens From Patients With Primary Malignant Tumors of the Heart

Protocol for the Examination of Specimens From Patients With Primary Malignant Tumors of the Heart Protocol for the Examination of Specimens From Patients With Primary Malignant Tumors of the Heart Protocol applies to primary malignant cardiac tumors. Hematolymphoid neoplasms are not included. No AJCC/UICC

More information

2018 ICD-O-3 Updates in Table Format with Annotation for Reference

2018 ICD-O-3 Updates in Table Format with Annotation for Reference Status Histology Description (this may be preferred term or a synonym) Report Comments New term 8010 3 Urachal carcinoma (C65.9, C66.9, C67._, C68._) New term 8013 3 Combined large cell neuroendocrine

More information

What s new in bone and soft tissue sarcoma Treatment and Guidelines 2012? Rob Grimer

What s new in bone and soft tissue sarcoma Treatment and Guidelines 2012? Rob Grimer What s new in bone and soft tissue sarcoma Treatment and Guidelines 2012? Rob Grimer ESMO conference 2012 Top Oncologists in world (~ 400) Lots of sarcoma basic science key messages: 40% of STS diagnoses

More information

USCAP COMPANION MEETING INTERNATIONAL SOCIETY OF BONE AND SOFT TISSUE PATHOLOGY DENVER, March 2 nd 2008

USCAP COMPANION MEETING INTERNATIONAL SOCIETY OF BONE AND SOFT TISSUE PATHOLOGY DENVER, March 2 nd 2008 1 USCAP COMPANION MEETING INTERNATIONAL SOCIETY OF BONE AND SOFT TISSUE PATHOLOGY DENVER, March 2 nd 2008 THE EVOLUTION OF SOFT TISSUE TUMOUR TAXONOMY: WHAT STILL NEEDS TO BE DONE? Christopher D.M. Fletcher,

More information

J Clin Oncol 30: by American Society of Clinical Oncology INTRODUCTION

J Clin Oncol 30: by American Society of Clinical Oncology INTRODUCTION VOLUME 3 NUMBER 8 MARCH 1 212 JOURNAL OF CLINICAL ONCOLOGY O R I G I N A L R E P O R T Short, Full-Dose Adjuvant Chemotherapy in High-Risk Adult Soft Tissue Sarcomas: A Randomized Clinical Trial From the

More information

Guidelines Guidelines for the Management of Soft Tissue Sarcomas

Guidelines Guidelines for the Management of Soft Tissue Sarcomas Hindawi Publishing Corporation Sarcoma Volume 2010, Article ID 506182, 15 pages doi:10.1155/2010/506182 Guidelines Guidelines for the Management of Soft Tissue Sarcomas Robert Grimer, 1 Ian Judson, 2 David

More information

Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia

Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia Tumores de células pequeñas, redondas y azules: diagnóstico diferencial cuando el tiempo apremia Sílvia Bagué Servei de Patologia Hospital de Sant Pau Barcelona Soft tissue sarcomas Heterogeneous group

More information

Radio-Pathologic Workup of a Retroperitoneal Abdominal Mass

Radio-Pathologic Workup of a Retroperitoneal Abdominal Mass Radio-Pathologic Workup of a Retroperitoneal Abdominal Mass Joe Carlson Advanced Radiology Clerkship Harvard Medical School Year IV September 12, 2002 84 year old Male Presented to PCP With Abdominal Pain

More information

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group)

Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) Shared Care & Survival CTYA SSCRG (Childhood Cancer Research Group) January 2013 The NCIN is a UK-wide initiative, working to drive improvements in standards of cancer care and clinical outcomes by improving

More information

Slide seminar: Soft tissue and bone pathology

Slide seminar: Soft tissue and bone pathology Slide seminar: Soft tissue and bone pathology Unusual tumors of bone and soft tissue or unusual presentations of common ones Gunhild Mechtersheimer Institute of Pathology, Heidelberg/DE (Sylvia Höller,

More information

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific Effective January 1, 2018 codes, behaviors and terms are site specific /N 8551/3 Acinar adenocarcinoma (C34. _) Lung primaries diagnosed prior to 1/1/2018 use code 8550/3 For prostate (all years) see 8140/3

More information

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific

Effective January 1, 2018 ICD O 3 codes, behaviors and terms are site specific Effective January 1, 2018 codes, behaviors and terms are site specific Status /N 8010/3 Urachal carcinoma (C65.9, C66.9, C67. _, C68._) 8013/3 Combined large cell neuroendocrine carcinoma (C34. _, C37.9)

More information

Molecular Diagnosis of Soft Tissue Tumors: Avoid Pitfalls

Molecular Diagnosis of Soft Tissue Tumors: Avoid Pitfalls Molecular Diagnosis of Soft Tissue Tumors: Avoid Pitfalls Cristina Antonescu, MD Department of Pathology Memorial Sloan-Kettering Cancer Center, New York Overview I. When should we rely on the help of

More information

Houston, Texas, USA. Key Words. Soft tissue sarcoma Adjuvant Neoadjuvant Chemotherapy

Houston, Texas, USA. Key Words. Soft tissue sarcoma Adjuvant Neoadjuvant Chemotherapy The Oncologist The Oncologist CME Program is located online at http://cme.theoncologist.com/. To take the CME activity related to this article, you must be a registered user. Sarcomas Should Patients with

More information

Frank Peinemann, 1 Alexander M Labeit 2

Frank Peinemann, 1 Alexander M Labeit 2 Research Autologous haematopoietic stem cell transplantation following high-dose chemotherapy for non-rhabdomyosarcoma soft tissue sarcomas: a Cochrane systematic review* Frank Peinemann, 1 Alexander M

More information

Citation for published version (APA): Komdeur, R. (2003). Resistance and perspectives in soft tissue sarcomas s.n.

Citation for published version (APA): Komdeur, R. (2003). Resistance and perspectives in soft tissue sarcomas s.n. University of Groningen Resistance and perspectives in soft tissue sarcomas Komdeur, Rudy IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.

More information

Practical Issues for Retroperitoneal Sarcoma

Practical Issues for Retroperitoneal Sarcoma Pathology Report Practical Issues for Retroperitoneal Sarcoma Vicky Pham, MS, Evita Henderson-Jackson, MD, Matthew P. Doepker, MD, Jamie T. Caracciolo, MD, Ricardo J. Gonzalez, MD, Mihaela Druta, MD, Yi

More information

Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas

Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas ORIGINAL ARTICLE The ANNALS of AFRICAN SURGERY www.sskenya.org Recurrence and Mortality after Surgical Treatment of Soft Tissue Sarcomas Motanya JB 1, Saidi H 2 1 Molo District Hospital, Nakuru, Kenya

More information

Sarcoma Expert Advisory Group (SAG) Clinical Guidelines 2017

Sarcoma Expert Advisory Group (SAG) Clinical Guidelines 2017 Sarcoma Expert Advisory Group (SAG) Clinical Guidelines 2017 Document Information Title: Sarcoma Advisory Group Constitution Author: Mr C Gerrand, Consultant Orthopaedic Surgeon Circulation List: Sarcoma

More information

S2199 S2200. * Speaker's diagnosis 78

S2199 S2200. * Speaker's diagnosis 78 98 21 2 14 13:30 * Speaker's diagnosis 78 S2199 Meningioma 48 Papillary meningioma * 30 Angiomatous meningioma 15 Ependymoma 12 Papillary ependymoma 6 Anaplastic ependymoma 2 Cellular ependymoma 1 Hemangioblastoma

More information

UnitedHealthcare Pharmacy Clinical Pharmacy Programs

UnitedHealthcare Pharmacy Clinical Pharmacy Programs UnitedHealthcare Pharmacy Clinical Pharmacy Programs Program Number 2018 P 1067-7 Program Prior Authorization/Notification Medication Nexavar (sorafenib tosylate) P&T Approval Date 8/2008, 6/2009, 6/2010,

More information

Retroperitoneal Sarcomas - A pictorial review

Retroperitoneal Sarcomas - A pictorial review Retroperitoneal Sarcomas - A pictorial review Poster No.: C-1409 Congress: ECR 2013 Type: Educational Exhibit Authors: D. Douraghi-Zadeh, K. L. Shahabuddin, R. H. Thomas, E. Moskovic; London/UK Keywords:

More information

Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology

Diplomate of the American Board of Pathology in Anatomic and Clinical Pathology A 33-year-old male with a left lower leg mass. Contributed by Shaoxiong Chen, MD, PhD Assistant Professor Indiana University School of Medicine/ IU Health Partners Department of Pathology and Laboratory

More information

KEY ADVANCES IN THE SYSTEMIC THERAPY FOR SOFT TISSUE SARCOMAS: CURRENT STATUS AND FUTURE DIRECTIONS

KEY ADVANCES IN THE SYSTEMIC THERAPY FOR SOFT TISSUE SARCOMAS: CURRENT STATUS AND FUTURE DIRECTIONS KEY ADVANCES IN THE SYSTEMIC THERAPY FOR SOFT TISSUE SARCOMAS: CURRENT STATUS AND FUTURE DIRECTIONS Neelesh Soman, 1 James Hu, 2 Vivek Subbiah, 3 and Sant Chawla 1 1. Sarcoma Oncology Center, Santa Monica,

More information

RESEARCH ARTICLE. Soft-tissue Sarcomas in the Asia-Pacific Region: A Systematic Review

RESEARCH ARTICLE. Soft-tissue Sarcomas in the Asia-Pacific Region: A Systematic Review DOI:http://dx.doi.org/10.7314/APJCP.2013.14.11.6821 Soft-tissue Sarcoma in the Asia-Pacific Region: A Systematic Review RESEARCH ARTICLE Soft-tissue Sarcomas in the Asia-Pacific Region: A Systematic Review

More information